TerminatedNot applicableNCT03730519
UK Registry for Baroreflex Activation Therapy
Studying Baroreflex failure
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Queen Mary University of London
- Principal Investigator
- Melvin D Lobo, MBChB PhDQueen Mary University of London
- Intervention
- Baroreflex Activation Therapy with Barostim Neo(device)
- Enrollment
- 6 enrolled
- Eligibility
- 18-80 years · All sexes
- Timeline
- 2018 – 2021
Study locations (1)
- William Harvey Research Institute, London, United Kingdom
Collaborators
CVRx, Inc.
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03730519 on ClinicalTrials.gov